chr2-3575351-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PM2PP3_StrongPP5_Moderate
The NM_001011.4(RPS7):c.-19+1G>A variant causes a splice donor change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
RPS7
NM_001011.4 splice_donor
NM_001011.4 splice_donor
Scores
2
Splicing: ADA: 0.9999
2
Clinical Significance
Conservation
PhyloP100: 2.18
Genes affected
RPS7 (HGNC:10440): (ribosomal protein S7) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S7E family of ribosomal proteins. It is located in the cytoplasm. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 2-3575351-G-A is Pathogenic according to our data. Variant chr2-3575351-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 975849.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPS7 | NM_001011.4 | c.-19+1G>A | splice_donor_variant | ENST00000645674.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPS7 | ENST00000645674.2 | c.-19+1G>A | splice_donor_variant | NM_001011.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Diamond-Blackfan anemia 8 Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genomics Laboratory, Stanford Medicine | Dec 30, 2019 | The c.-19+1G>A variant in the RPS7 gene was identified de novo in this individual, but has not been previously reported in association with disease and was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant alters the canonical donor splice site in intron 1, which is predicted to result in abnormal gene splicing. Heterozygous loss of function is an established mechanism of disease for the RPS7 gene. Notably, different nucleotide changes (c.-19+1G>C, c.- 19+1G>T, c.-19+2T>C) disrupting the same canonical splice site have been previously reported (Smetanina et al., 2015; van Dooijeweert et al., 2018). These reported disease-causing variant are expected to result in a similar disruption to protein function as c.-19+1G>A. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the c.-19+1G>A variant as pathogenic for autosomal dominant Diamond-Blackfan anemia based on the information above. [ACMG evidence codes used: PVS1_Strong; PS2; PM2] - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous c.-19+1G>A variant in RPS7 was identified by our study in one individual with Diamond-Blackfan anemia. The c.-19+1G>A variant in RPS7 has not been previously reported in individuals with Diamond-Blackfan anemia 8. This variant was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 975849) and has been interpreted as pathogenic by the Stanford Medicine Clinical Genomics Program. This variant was found de novo in one individual with confirmed paternity and maternity (ClinVar Variation ID: 975849). A different nucleotide change at the same site (i.e., the 5’-UTR splice-site of the RPS7 first exon), c.-19+1G>T (PMID: 36057918) has been previously reported pathogenic, and the variant being assessed here, c.-19+1G>A, is predicted by SpliceAI to have a similar effect on splicing. This variant is located in the 5' splice region. Computational tools predict a splicing impact, though this information is not predictive enough to determine pathogenicity. Heterozygous loss of function of the RPS7 gene is an established disease mechanism in Diamond-Blackfan anemia 8. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant Diamond-Blackfan anemia 8. ACMG/AMP Criteria applied: PVS1_Strong, PS1_Supporting, PS2_Moderate, PM2_Supporting (Richards 2015). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: 3
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at